Multi-year collaboration expected to identify novel drug targets, tackle new subsets of disease and enable rapid progression of clinical programs
Anne Wojcicki discusses how 23andMe is becoming a player in medical research for age-old genetic diseases
For International Day of Families, 23andMe wanted to share with you what amounts to an international family story.Life has been good for Paul Knoll. He and his wife raised two sons...
The post Connecting with Family Across Borders appeared first on 23andMe Blog.
Already with almost half a million participants, including several thousand who have had the virus, 23andMe is expanding its COVID-19 genetics study. The study is now open to people who have been hospitalized with severe cases of the virus but are not currently 23andMe customers.
The post 23andMe Expands its Genetic Study of COVID-19 appeared first on 23andMe Blog.
A new 23andMe study found that many with a BRCA genetic variant associated with an increased risk for breast, ovarian, and other cancers do not have a strong family history of cancer meaning they would likely not qualify for clinical genetic testing under current criteria.
The post New 23andMe BRCA Study Published appeared first on 23andMe Blog.
A 23andMe skeptic changes her mind after testing and learning that she had genetic predispositions for Celiac disease and Type 2 diabetes, two conditions she has.
The post A 23andMe Skeptic Changes Her Mind appeared first on 23andMe Blog.